Cargando...
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling and analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blo...
Gardado en:
| Publicado en: | J Pathol Transl Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7253954/ https://ncbi.nlm.nih.gov/pubmed/32460474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2020.02.27 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|